Drugs / AZD4451
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01196676 | Aug 2010 → Apr 2011 | bipolar disorder | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD4451 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01196676 ↗ |
| Route | Oral | “Following Single Ascending Oral Dose Administration” NCT01196676 ↗ |